Avalon globocare reports laboratory services mso revenue of $14.7 million and net income of $6.3 million in 2022

40% profit sharing arrangement with laboratory services mso is expected to result in significant future cash flow to the company 40% profit sharing arrangement with laboratory services mso is expected to result in significant future cash flow to the company
ALBT Ratings Summary
ALBT Quant Ranking